The poly(ADP-ribose) polymerase (PARP) is involved in cell recovery from DNA damage, such as methylation of N3-adenine, that activates the base excision repair process. In the present study we demonstrated that MeOSO2(CH2)(2)-lexitropsin (Me-Lex), a methylating agent that almost exclusively produces N3-methyladenine, induced different modalities of cell death in human leukemic cell lines, depending on the presence of PARP inhibitor. Growth inhibition, provoked by the combination of Me-Lex and PARP inhibitor, was associated with a marked down-regulation of c-myc, increased generation of single strand breaks and apoptosis, When used as single agent, at concentrations that saturated cell repair ability, Me-Lex induced mainly cell death by necr...
We recently demonstrated that poly(ADP-ribose) polymerase (PARP)-1 is involved in angiogenesis and t...
We recently demonstrated that poly(ADP-ribose) polymerase (PARP)-1 is involved in angiogenesis and t...
We recently demonstrated that poly(ADP-ribose) polymerase (PARP)-1 is involved in angiogenesis and t...
The poly(ADP-ribose) polymerase (PARP) is involved in cell recovery from DNA damage, such as methyla...
Methylation of N3-adenine represents a novel pharmacological strategy for the treatment of resistant...
Selective methylation of N3-adenine represents a novel pharmacological strategy for the treatment of...
We recently demonstrated that mismatch repair deficient tumor cells, that are tolerant to O6-methyl ...
Mismatch repair deficiency contributes to tumor cell resistance to O-6-guanine methylating compounds...
Selective N3-adenine methylation represents a novel strategy for tumors with a phenotype of poor res...
We recently demonstrated that poly(ADP-ribose) polymerase (PARP)-1 is involved in angiogenesis and t...
We recently demonstrated that poly(ADP-ribose) polymerase (PARP)-1 is involved in angiogenesis and t...
We recently demonstrated that poly(ADP-ribose) polymerase (PARP)-1 is involved in angiogenesis and t...
The poly(ADP-ribose) polymerase (PARP) is involved in cell recovery from DNA damage, such as methyla...
Methylation of N3-adenine represents a novel pharmacological strategy for the treatment of resistant...
Selective methylation of N3-adenine represents a novel pharmacological strategy for the treatment of...
We recently demonstrated that mismatch repair deficient tumor cells, that are tolerant to O6-methyl ...
Mismatch repair deficiency contributes to tumor cell resistance to O-6-guanine methylating compounds...
Selective N3-adenine methylation represents a novel strategy for tumors with a phenotype of poor res...
We recently demonstrated that poly(ADP-ribose) polymerase (PARP)-1 is involved in angiogenesis and t...
We recently demonstrated that poly(ADP-ribose) polymerase (PARP)-1 is involved in angiogenesis and t...
We recently demonstrated that poly(ADP-ribose) polymerase (PARP)-1 is involved in angiogenesis and t...